Different prevalence and clinical outcome of Epstein-Barr virus positive diffuse large B-cell lymphoma between North American and non-Western populations.
Publication
, Journal Article
Yin, L; Xu-Monette, ZY; Brock, J; Li, Y; Young, KH
Published in: Ann Transl Med
June 2018
Duke Scholars
Published In
Ann Transl Med
DOI
ISSN
2305-5839
Publication Date
June 2018
Volume
6
Issue
11
Start / End Page
236
Location
China
Related Subject Headings
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Yin, L., Xu-Monette, Z. Y., Brock, J., Li, Y., & Young, K. H. (2018). Different prevalence and clinical outcome of Epstein-Barr virus positive diffuse large B-cell lymphoma between North American and non-Western populations. Ann Transl Med, 6(11), 236. https://doi.org/10.21037/atm.2018.05.36
Yin, Lihui, Zijun Y. Xu-Monette, Jay Brock, Yong Li, and Ken H. Young. “Different prevalence and clinical outcome of Epstein-Barr virus positive diffuse large B-cell lymphoma between North American and non-Western populations.” Ann Transl Med 6, no. 11 (June 2018): 236. https://doi.org/10.21037/atm.2018.05.36.
Yin L, Xu-Monette ZY, Brock J, Li Y, Young KH. Different prevalence and clinical outcome of Epstein-Barr virus positive diffuse large B-cell lymphoma between North American and non-Western populations. Ann Transl Med. 2018 Jun;6(11):236.
Yin, Lihui, et al. “Different prevalence and clinical outcome of Epstein-Barr virus positive diffuse large B-cell lymphoma between North American and non-Western populations.” Ann Transl Med, vol. 6, no. 11, June 2018, p. 236. Pubmed, doi:10.21037/atm.2018.05.36.
Yin L, Xu-Monette ZY, Brock J, Li Y, Young KH. Different prevalence and clinical outcome of Epstein-Barr virus positive diffuse large B-cell lymphoma between North American and non-Western populations. Ann Transl Med. 2018 Jun;6(11):236.
Published In
Ann Transl Med
DOI
ISSN
2305-5839
Publication Date
June 2018
Volume
6
Issue
11
Start / End Page
236
Location
China
Related Subject Headings
- 42 Health sciences
- 32 Biomedical and clinical sciences